These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 9530038)
1. Localized form of bronchioloalveolar carcinoma: FDG PET findings. Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038 [TBL] [Abstract][Full Text] [Related]
2. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862 [TBL] [Abstract][Full Text] [Related]
3. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938 [TBL] [Abstract][Full Text] [Related]
4. Correlation of Glut-1 glucose transporter expression with. Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940 [TBL] [Abstract][Full Text] [Related]
5. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. Higashi K; Ueda Y; Seki H; Yuasa K; Oguchi M; Noguchi T; Taniguchi M; Tonami H; Okimura T; Yamamoto I J Nucl Med; 1998 Jun; 39(6):1016-20. PubMed ID: 9627336 [TBL] [Abstract][Full Text] [Related]
6. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264 [TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers. Sun JS; Park KJ; Sheen SS; Yoon JK; Yoon SN; Lee KB; Hwang SC Lung Cancer; 2009 Nov; 66(2):205-10. PubMed ID: 19203812 [TBL] [Abstract][Full Text] [Related]
8. High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients. Akira M; Atagi S; Kawahara M; Iuchi K; Johkoh T AJR Am J Roentgenol; 1999 Dec; 173(6):1623-9. PubMed ID: 10584811 [TBL] [Abstract][Full Text] [Related]
9. Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma. Raz DJ; Odisho AY; Franc BL; Jablons DM J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1189-95. PubMed ID: 17059942 [TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size. Tsunezuka Y; Shimizu Y; Tanaka N; Takayanagi T; Kawano M World J Surg; 2007 Feb; 31(2):314-7. PubMed ID: 17219276 [TBL] [Abstract][Full Text] [Related]
11. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Yap CS; Schiepers C; Fishbein MC; Phelps ME; Czernin J Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1166-73. PubMed ID: 12192561 [TBL] [Abstract][Full Text] [Related]
12. Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign. Jang HJ; Lee KS; Kwon OJ; Rhee CH; Shim YM; Han J Radiology; 1996 May; 199(2):485-8. PubMed ID: 8668800 [TBL] [Abstract][Full Text] [Related]
13. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer]. Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097 [TBL] [Abstract][Full Text] [Related]
14. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity? Kim TJ; Park CM; Goo JM; Lee KW AJR Am J Roentgenol; 2012 Jan; 198(1):83-8. PubMed ID: 22194482 [TBL] [Abstract][Full Text] [Related]
16. Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT. Derlin T; Clauditz TS; Quaas A; Habermann CR Clin Nucl Med; 2012 Oct; 37(10):e255-6. PubMed ID: 22899191 [TBL] [Abstract][Full Text] [Related]
17. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. Okada M; Nishio W; Sakamoto T; Uchino K; Hanioka K; Ohbayashi C; Tsubota N J Thorac Cardiovasc Surg; 2004 Mar; 127(3):857-61. PubMed ID: 15001917 [TBL] [Abstract][Full Text] [Related]
18. Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings. Sawada E; Nambu A; Motosugi U; Araki T; Kato S; Sato Y; Saito A; Ishihara H; Okuwaki H; Ozawa K; Nishikawa K; Miyazawa M; Miyata K Jpn J Radiol; 2010 May; 28(4):251-8. PubMed ID: 20512541 [TBL] [Abstract][Full Text] [Related]
19. Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung. Kuriyama K; Seto M; Kasugai T; Higashiyama M; Kido S; Sawai Y; Kodama K; Kuroda C AJR Am J Roentgenol; 1999 Aug; 173(2):465-9. PubMed ID: 10430155 [TBL] [Abstract][Full Text] [Related]
20. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography. Nomori H; Kosaka N; Watanabe K; Ohtsuka T; Naruke T; Kobayashi T; Uno K Ann Thorac Surg; 2005 Dec; 80(6):2020-5. PubMed ID: 16305837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]